Governing the AI–biotech convergence

EMBO Reports 2026 Open access

Read full text
Authors: Benjamin D. Trump, Christopher L. Cummings, Beth Ellinport, Stephanie Galaitsi, Thomas Janisko, Elizaveta Pinigina, Hannah Herzig, Cindy S Groff-Vindman, Markus Schmidt, Gerald L. Epstein, Ruth Mampuys, Christian Haggenmiller
+5 more Tatyana Novossiolova, Travis B. Tubbs, James H Lambert, Alexander Titus, Igor Linkov
DOI: 10.1038/s44319-025-00628-w
Cited by: 5
References: 24

Abstract

The convergence of artificial intelligence with biotechnology accelerates innovation but also introduces significant ethical and security risks. These require adaptive, flexible governance strategies that ensure that breakthroughs can be managed responsibly while mitigating potential risks.

Fields of Study & Subjects

Law AI and Intellectual Property Neuroethics Human Enhancement Biomedical Innovations Ethics and Social Impacts of AI

Publication details

Journal / source
EMBO Reports
Publisher
Springer Science and Business Media LLC
Volume
27
Issue
2
Pages
259–264
Publication date
3 January 2026
Language
EN